Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial

Neurology

Volumn 78, Issue 24, 2012, Pages 1959-1966

  Herzog, A G ^a   Fowler, K M ^a   Smithson, S D ^a   Kalayjian, L A ^b   Heck, C N ^b   Sperling, M R ^c   Liporace, J D ^c   Harden, C L ^d   Dworetzky, B A ^e   Pennell, P B ^e   Massaro, J M ^f  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; PHENYTOIN; PLACEBO; PROGESTERONE; TOPIRAMATE;

ADOLESCENT; ADULT; ARTICLE; BLURRED VISION; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; FEMALE; FOCAL EPILEPSY; HUMAN; INSOMNIA; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTICENTER STUDY; NAUSEA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH DISEASE; THYROID CARCINOMA; TREATMENT OUTCOME; VOMITING;

EID: 84863558764     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318259e1f9     Document Type: Article

References (21)

1. Tauboll E, Lundervold A, Gjerstad L. Temporal distribution of seizures in epilepsy. Epilepsy Res 1991;8:153-165.
2. Herzog AG. Catamenial epilepsy: definition, prevalence, pathophysiology and treatment. Seizure 2008;17:151-159.
3. Quigg M, Smithson SD, Fowler KM, Sursal T, Herzog AG, Progesterone Trial Study Group. Laterality and location influence catamenial seizure expression in women with partial epilepsy. Neurology 2009;73:223-227.
4. Laidlaw J. Catamenial epilepsy. Lancet 1956;271:1235-1237.
5. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38:1082-1088.
6. A receptor complex. J Pharmacol Exp Ther 1987;241:346-353.
7. Kokate TG, Svensson BE, Rogawski M.A. Anticonvulsant activity of neurosteroids: correlation with g-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther 1994;270:1223-1229.
8. Frye CA. The neurosteroid 3a-5a-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res 1995;696:113-120.
9. Lawrence C, Martin BS, Sun C, Williamson J, Kapur J. Endogenous neurosteroid synthesis modulates seizure frequency. Ann Neurol 2010;67:689-693.
10. Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci 1994;14: 7680-7687.
11. Scharfman HE, Mercurio TC, Goodman JH, Wilson MA, MacLusky NJ. Hippocampal excitability increases during the estrous cycle in the rat: a potential role for brainderived neurotrophic factor. J Neurosci 2003;23:11641-11652.
12. Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res 2010; 186:113-137.
13. Maguire JL, Stell BM, Rafizadeh M, Mody I. Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 2005;8:797-804.
14. Quigg M, Smithson SD, Fowler KM, Sursal T, Herzog AG, Progesterone Trial Study Group. Laterality and location influence catamenial seizure expression in women with partial epilepsy. Neurology 2009;73:223-227.
15. Betts T, Waegemans T, Crawford P. A multicentre, double-blind, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure 2000;9:80-87.
16. Barcs G, Walker EB, Elger CE, et al. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 2000;41:1597-1607.
17. Marinus Pharmaceuticals March 3, 2009 announcement. Available at: http://www.marinuspharma.com/nr-positive-results.html. March 3, 2009.
18. Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 1984;34:1255-1258.
19. Bauer J, Wildt L, Flugel D, Stefan H. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients. J Neurol 1992;239:284-286.
20. Haider Y, Barnett DB. Catamenial epilepsy and goserelin. Lancet 1991;338:1530.
21. Reid B, Gangar KF. Catamenial epilepsy and goserelin. Lancet 1992;339:253.